Cormorant Asset Management »

Roivant Sciences Ltd Shs Isin #bmg762791017 shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Roivant Sciences Ltd Shs Isin #bmg762791017

Tip: Access up to 7 years of quarterly data

All positions including Roivant Sciences Ltd Shs Isin #bmg762791017 held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Roivant Sciences Ltd Shs Isin #bmg762791017 by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $21M 750k 27.70

More positions owned by Cormorant Asset Management

Praxis Precision Medicines I Com New (PRAX)
Bridgebio Oncology Therapeut Com New (BBOT)
Eyepoint Com New (EYPT)
Edgewise Therapeutics (EWTX)
Erasca (ERAS)
Rapport Therapeutics (RAPP)
Alumis (ALMS)
Abivax Sa Sponsored Ads (ABVX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Dianthus Therapeutics (DNTH)
Bright Minds Biosciences Com New (DRUG)
Olema Pharmaceuticals (OLMA)
Bridgebio Pharma (BBIO)
Bioage Labs (BIOA)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for Cormorant Asset Management

Top funds holding Roivant Sciences Ltd Shs Isin #bmg762791017

FMR
Morgan Stanley
BlackRock
Vanguard Group
QVT Financial
UBS Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Goldman Sachs Group
Adage Capital Partners GP
Geode Capital Management
Two Seas Capital
Perceptive Advisors
Patient Square Capital

View all funds holding Roivant Sciences Ltd Shs Isin #bmg762791017